ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32404-10mM(1mLinDMSO) |
|
96-83-3 |
Iopanoic acid
|
0 | C11H12I3NO2 | |
GC32403-100mg |
|
917891-35-1 |
LGD-3303
|
0 | C16H14ClF3N2O | |
GC32403-50mg |
|
917891-35-1 |
LGD-3303
|
0 | C16H14ClF3N2O | |
GC32403-25mg |
|
917891-35-1 |
LGD-3303
|
0 | C16H14ClF3N2O | |
GC32403-10mg |
|
917891-35-1 |
LGD-3303
|
0 | C16H14ClF3N2O | |
GC32403-5mg |
|
917891-35-1 |
LGD-3303
|
0 | C16H14ClF3N2O | |
GC32403-10mM(1mLinDMSO) |
|
917891-35-1 |
LGD-3303
|
0 | C16H14ClF3N2O | |
GC32402-100mg |
|
1297537-33-7 |
ORM-15341
|
0 | C19H17ClN6O2 | |
GC32402-50mg |
|
1297537-33-7 |
ORM-15341
|
0 | C19H17ClN6O2 | |
GC32402-10mg |
|
1297537-33-7 |
ORM-15341
|
0 | C19H17ClN6O2 | |
GC32402-5mg |
|
1297537-33-7 |
ORM-15341
|
0 | C19H17ClN6O2 | |
GC32402-10mM(1mLinDMSO) |
|
1297537-33-7 |
ORM-15341
|
0 | C19H17ClN6O2 | |
GC32400-50mg |
|
1156-19-0 |
Tolazamide (U-17835)
|
0 | C14H21N3O3S | |
GC32400-10mg |
|
1156-19-0 |
Tolazamide (U-17835)
|
0 | C14H21N3O3S | |
GC32400-10mM(1mLinDMSO) |
|
1156-19-0 |
Tolazamide (U-17835)
|
0 | C14H21N3O3S | |
GC32399-100mg |
|
308831-61-0 |
Sufugolix (TAK-013)
|
0 | C36H31F2N5O4S | |
GC32399-50mg |
|
308831-61-0 |
Sufugolix (TAK-013)
|
0 | C36H31F2N5O4S | |
GC32399-25mg |
|
308831-61-0 |
Sufugolix (TAK-013)
|
0 | C36H31F2N5O4S | |
GC32399-10mg |
|
308831-61-0 |
Sufugolix (TAK-013)
|
0 | C36H31F2N5O4S | |
GC32399-5mg |
|
308831-61-0 |
Sufugolix (TAK-013)
|
0 | C36H31F2N5O4S | |